TCL Archive Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says. November 23, 2005
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Brief: James Institute Receives $9 Million Gift; NCI’s Fraumeni Wins Public Health Award November 3, 1995
